AETHLON MEDICAL, INC.: 10-Q filed 2020-10-28

Name: AETHLON MEDICAL, INC.: 10-Q filed 2020-10-28
Creator: AETHLON MEDICAL, INC.

What AETHLON MEDICAL, INC. reported in its quarterly report filed 2020-10-28 (fiscal Q2 2021): 36 published measures, 96 facts as tagged in accession 0001683168-20-003583.

This filing

Form: 10-Q (quarterly report)
Filed: 2020-10-28
Fiscal period: fiscal Q2 2021
Accession: 0001683168-20-003583 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All AETHLON MEDICAL, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit
At 2020-09-30	15,056,390	USD
At 2020-03-31	10,387,686	USD
At 2019-09-30	1,281,790	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2020-09-30	1,489,760	USD
At 2020-03-31	1,110,260	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2020-09-30	13,700,442	USD
At 2020-03-31	9,409,550	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2020-07-01 to 2020-09-30	-1,770,564	USD	92
2020-04-01 to 2020-09-30	-3,180,847	USD	183
2019-07-01 to 2019-09-30	-1,705,037	USD	92
2019-04-01 to 2019-09-30	-3,771,461	USD	183

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2020-04-01 to 2020-09-30	-2,328,901	USD	183
2019-04-01 to 2019-09-30	-2,320,866	USD	183

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2020-04-01 to 2020-09-30	23,137	USD	183
2019-04-01 to 2019-09-30	119,981	USD	183

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Value	Unit	Days
2020-07-01 to 2020-09-30	0	USD	92
2020-04-01 to 2020-09-30	0	USD	183
2019-07-01 to 2019-09-30	0	USD	92
2019-04-01 to 2019-09-30	30,000	USD	183

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2020-04-01 to 2020-09-30	7,220,490	USD	183
2019-04-01 to 2019-09-30	-601,569	USD	183

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2020-04-01 to 2020-09-30	-23,137	USD	183
2019-04-01 to 2019-09-30	-119,981	USD	183

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2020-09-30	-115,207,228	USD
At 2020-03-31	-112,026,381	USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2020-09-30	145,855	USD
At 2020-03-31	140,484	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2020-07-01 to 2020-09-30	167,042	USD	92
2020-04-01 to 2020-09-30	251,249	USD	183
2019-07-01 to 2019-09-30	326,536	USD	92
2019-04-01 to 2019-09-30	653,072	USD	183

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2020-07-01 to 2020-09-30	-1,771,389	USD	92
2020-04-01 to 2020-09-30	-3,181,807	USD	183
2019-07-01 to 2019-09-30	-1,702,202	USD	92
2019-04-01 to 2019-09-30	-3,268,391	USD	183

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2020-09-30	14,752,259	USD
At 2020-03-31	10,041,113	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2019-04-01 to 2019-09-30	54,046	USD	183

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2020-09-30	1,489,760	USD
At 2020-03-31	1,067,720	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2020-09-30	311,724	USD
At 2020-03-31	285,036	USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

Period	Value	Unit	Days
At 2020-09-30	57,229	USD
At 2020-03-31	57,504	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2020-09-30	111,849	USD
At 2020-03-31	206,729	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2020-07-01 to 2020-09-30	1,771,389	USD	92
2020-04-01 to 2020-09-30	3,181,807	USD	183
2019-07-01 to 2019-09-30	1,702,202	USD	92
2019-04-01 to 2019-09-30	3,298,391	USD	183

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2020-07-01 to 2020-09-30	508,897	USD	92
2020-04-01 to 2020-09-30	884,985	USD	183
2019-07-01 to 2019-09-30	222,857	USD	92
2019-04-01 to 2019-09-30	470,882	USD	183

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2020-09-30	12,088,313	shares
At 2020-03-31	9,366,873	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2020-09-30	128,895,581	USD
At 2020-03-31	121,426,563	USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

Period	Value	Unit
At 2020-09-30	13,566,630	USD
At 2020-06-30	15,187,105	USD
At 2020-03-31	9,277,426	USD
At 2019-09-30	20,672	USD
At 2019-06-30	1,018,192	USD
At 2019-03-31	2,299,078	USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

Period	Value	Unit
At 2020-09-30	88,888	USD
At 2020-04-02	228,694	USD
At 2020-03-31	136,426	USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

Period	Value	Unit	Days
At 2020-04-02	228,694	USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

Period	Value	Unit	Days
At 2020-09-30	167,178	USD
At 2020-03-31	229,604	USD

Current contract liabilities

Consideration received before performance obligations are satisfied, often called deferred revenue. It is an obligation to deliver, not earned revenue or cash available.

Period	Value	Unit	Days
At 2020-09-30	507,022	USD
At 2020-03-31	100,000	USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

Period	Value	Unit	Days
2020-07-01 to 2020-09-30	-1,771,389	USD	92
2020-04-01 to 2020-09-30	-3,182,535	USD	183
2019-07-01 to 2019-09-30	-1,706,626	USD	92
2019-04-01 to 2019-09-30	-3,773,911	USD	183

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

Period	Value	Unit	Days
2020-07-01 to 2020-09-30	-1,771,389	USD	92
2020-04-01 to 2020-06-30	-1,411,146	USD	91
2019-07-01 to 2019-09-30	-1,706,626	USD	92
2019-04-01 to 2019-06-30	-2,067,284	USD	91

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2020-07-01 to 2020-09-30	554,749	USD	92
2020-04-01 to 2020-09-30	963,972	USD	183
2019-07-01 to 2019-09-30	342,339	USD	92
2019-04-01 to 2019-09-30	724,955	USD	183

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

Period	Value	Unit	Days
2020-04-01 to 2020-09-30	18,041	USD	183
2019-04-01 to 2019-09-30	5,751	USD	183

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2020-07-01 to 2020-09-30	0	USD	92
2020-04-01 to 2020-09-30	-728	USD	183
2019-07-01 to 2019-09-30	-4,424	USD	92
2019-04-01 to 2019-09-30	-505,520	USD	183

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

Period	Value	Unit	Days
2020-04-01 to 2020-09-30	0	USD	183
2019-04-01 to 2019-09-30	83,332	USD	183

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

Period	Value	Unit	Days
2020-04-01 to 2020-09-30	7,260,869	USD	183
2019-04-01 to 2019-09-30	423,234	USD	183

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2020-04-01 to 2020-09-30	-94,880	USD	183
2019-04-01 to 2019-09-30	0	USD	183

Inspect the source

Entity: AETHLON MEDICAL, INC. / CIK 0000882291
Captured: 2026-09-20T05:01:59.680Z
SEC response SHA-256: 8edef8396a760acc426ab35ab8234b202fee7f6b25b28f476090f7f70ae3999f

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000882291.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))